“We recognize this purchase is a significant milestone and growth opportunity for our staff and the Bristol community,” said Pine Lake Laboratories President, Kurt Moyer, Ph.D. “We plan to continue NSF International’s legacy of scientific and technical expertise and to serve our global clients. Moving forward as Pine Lake Laboratories, with our group of scientists and professionals, we will continue to grow our operations, enhance technologies and help our clients produce safer pharmaceuticals and medical devices here in Bristol.”

Along with Dr. Moyer, the Pine Lake Laboratories’ core leadership team includes group leaders Ulyana Matyugicheva and Cassandra Tellarini.

Dr. Moyer has more than 25 years of experience in pharmaceutical development. In his previous role as Director of Research at NSF International, he led all analytical, bioanalytical, and extractables and leachables studies. Prior to joining NSF International, he worked with Sanofi-Aventis as a senior research scientist and DuPont Pharmaceuticals as a senior research investigator. Dr. Moyer earned a Ph.D. in biochemistry from Villanova University and a bachelor of science in chemistry from Millersville University of Pennsylvania.

‍